251 related articles for article (PubMed ID: 32441651)
1. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
3. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
4. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
5. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
Hwang YS; Xianglan Z; Park KK; Chung WY
Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer.
Sasano T; Gonzalez-Delgado R; Muñoz NM; Carlos-Alcade W; Cho MS; Sheth RA; Sood AK; Afshar-Kharghan V
J Thromb Haemost; 2022 Jan; 20(1):104-114. PubMed ID: 34608736
[TBL] [Abstract][Full Text] [Related]
7. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
[TBL] [Abstract][Full Text] [Related]
8. PDPN
Li Y; Ma Z; Li W; Xu X; Shen P; Zhang SE; Cheng B; Xia J
Cell Death Dis; 2023 Nov; 14(11):759. PubMed ID: 37993428
[TBL] [Abstract][Full Text] [Related]
9. Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis.
Wang X; Liu B; Xu M; Jiang Y; Zhou J; Yang J; Gu H; Ruan C; Wu J; Zhao Y
Thromb Res; 2021 Apr; 200():72-80. PubMed ID: 33548843
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of podoplanin immunoexpression in oral and oropharyngeal squamous cell carcinoma: A systematic review.
Mello FW; Kammer PV; Silva CAB; Parkinson EK; Monteiro L; Warnakulasuriya S; Rivero ERC
J Oral Pathol Med; 2021 Jan; 50(1):1-9. PubMed ID: 32449167
[TBL] [Abstract][Full Text] [Related]
11. Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells.
Park SY; Lee SK; Lim M; Kim B; Hwang BO; Cho ES; Zhang X; Chun KS; Chung WY; Song NY
Biomol Ther (Seoul); 2022 May; 30(3):284-290. PubMed ID: 35110423
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells.
Costa B; Eisemann T; Strelau J; Spaan I; Korshunov A; Liu HK; Bugert P; Angel P; Peterziel H
Blood Adv; 2019 Apr; 3(7):1092-1102. PubMed ID: 30948364
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
14. Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression.
Ren H; He G; Lu Z; He Q; Li S; Huang Z; Chen Z; Cao C; Wang A
Cancer Sci; 2021 Jun; 112(6):2173-2184. PubMed ID: 33626219
[TBL] [Abstract][Full Text] [Related]
15. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
Tadokoro Y; Takeda D; Murakami A; Yatagai N; Saito I; Arimoto S; Kakei Y; Akashi M; Hasegawa T
PLoS One; 2023; 18(8):e0290357. PubMed ID: 37594996
[TBL] [Abstract][Full Text] [Related]
17. Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
Ukaji T; Takemoto A; Shibata H; Kakino M; Takagi S; Katayama R; Fujita N
Cancer Sci; 2021 Jun; 112(6):2299-2313. PubMed ID: 33735501
[TBL] [Abstract][Full Text] [Related]
18. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
[TBL] [Abstract][Full Text] [Related]
19. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
20. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
